On 12 Nov 2026 Brown–Forman closed at $30.04, +18.4% this year; market cap $13.80bn, P/E 19.1.
Consumer Staples · Distillers & Vintners · NYSE · United States
Brown-Forman Corporation, together with its subsidiaries, manufactures, distills, bottles, imports, exports, markets, and sells a variety of alcohol beverages. The company provides spirits, wines, whiskey spirits, whiskey-based flavored liqueurs, ready-to-drink cocktails, ready-to-pour products, vodkas, tequilas, gin, brandy, rum, bourbons, and liqueurs. The company offers its products primarily under the Jack Daniel's, Woodford Reserve, Old Forester, Gentleman Jack, Herradura, el Jimador, Fords Gin, The Glendronach, Chambord, Coopers' Craft, Diplomático, Benriach, Glenglassaugh, and Slane brands. It is also involved in the sale of used barrels, and bulk whiskey and wine; and provision of contract bottling services. The company serves retail customers and consumers through distributors and state governments; and retailers, wholesalers, and provincial governments directly. It operates in the United States, Germany, Australia, the United Kingdom, Canada, Spain, France, Mexico, Poland, Brazil, Türkiye, and internationally. Brown-Forman Corporation was founded in 1870 and is headquartered in Louisville, Kentucky.
| Market cap | $13.80bn |
| P/E (trailing) | 19.1 |
| EPS (TTM) | $1.57 |
| Beta | 0.31 |
| Dividend | $0.92 |
| Dividend yield | 3.06% |
| Ex-dividend date | 3 Sep 2026 |
| Latest report | 27 Aug 2026 |
| Next earnings | 25 Nov 2026 |
| YTD | +18.4% |
| 1Y | +13.7% |
| 3Y | -17.4% |
| 5Y | -14.1% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $3.93bn | $715.00m | $893.00m |
| 2025 | $3.98bn | $869.00m | $431.00m |
| 2024 | $4.18bn | $1.02bn | $419.00m |
| 2023 | $4.23bn | $783.00m | $457.00m |
| 2022 | $3.93bn | $838.00m | $798.00m |
We publish no single base value for Brown–Forman. Our valuation methods put it between $30.99 and $34.08 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.